Silencing of osteopontin promotes the radiosensitivity of breast cancer cells by reducing the expression of hypoxia inducible factor 1 and vascular endothelial growth factor
文献类型:期刊论文
刊名 | CHINESE MEDICAL JOURNAL
![]() |
出版日期 | 2012 |
卷号 | 125 |
关键词 | NASOPHARYNGEAL CARCINOMA RADIOTHERAPY HIF-1-ALPHA METASTASIS PHENOTYPE GENES MODEL VEGF breast cancer osteopontin small interfering RNA radiosensitivity |
ISSN号 | 0366-6999 |
其他题名 | Silencing of osteopontin promotes the radiosensitivity of breast cancer cells by reducing the expression of hypoxia inducible factor 1 and vascular endothelial growth factor |
英文摘要 | Background Osteopontin (OPN) is a secreted phosphoglycoprotein (SSP) that is overexpressed in a variety of tumors and was regarded as a molecular marker of tumors. In this study, we intended to demonstrate the role of OPN in human breast cancer cell line MDA-MB-231. |
资助项目 | [Shandong Natural Foundation of China] |
语种 | 英语 |
CSCD记录号 | CSCD:4432857 |
源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/62508] ![]() |
专题 | 中国科学院合肥物质科学研究院 |
推荐引用方式 GB/T 7714 | . Silencing of osteopontin promotes the radiosensitivity of breast cancer cells by reducing the expression of hypoxia inducible factor 1 and vascular endothelial growth factor[J]. CHINESE MEDICAL JOURNAL,2012,125. |
APA | (2012).Silencing of osteopontin promotes the radiosensitivity of breast cancer cells by reducing the expression of hypoxia inducible factor 1 and vascular endothelial growth factor.CHINESE MEDICAL JOURNAL,125. |
MLA | "Silencing of osteopontin promotes the radiosensitivity of breast cancer cells by reducing the expression of hypoxia inducible factor 1 and vascular endothelial growth factor".CHINESE MEDICAL JOURNAL 125(2012). |
入库方式: OAI收割
来源:合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。